Overall, treatment with semaglutide was associated with a reduction in the studys composite outcomecardiovascular death, nonfatal myocardial infarction or nonfatal strokeof 20% compared to a placebo, and it was linked to a safe and well-tolerated profile. SELECT trial results were published in the New England Journal of Medicine in November
"Boosts GLP-1" is not specific enough
Drug-Specific Effects on Blood Pressure and Organ Health Semaglutide and exenatide were associated with reductions in systolic blood pressure
Rudashevsky, NP Sep 2, 2025 9 min read Updated: Nov 17, 2025 Published by Medical Specialists MN | Reading Time: 8 minutes Key Takeaways What It Is: PT-141 (Bremelanotide) is a peptide therapy that works on the brain, not just blood vessels, to address both desire and physical arousal
Below, you can take a look at both the good and bad sides of this product